HLM Leads $16M Growth Investment in HPS/PayMedix; $33M Financing Raised

January 13, 2026

HPS/PayMedix closed $33 million of equity and debt financing to accelerate national growth of its healthcare financing and payments platform. The round was led by HLM Investment Partners ($16M growth equity) and included Escalate Capital Partners (providing a $17M term debt facility), RVM Enterprises, and existing investor SV Health Investors.

Buyers
HLM Investment Partners, Escalate Capital Partners, RVM Enterprises, SV Health Investors
Targets
HPS/PayMedix
Location
Wisconsin, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.